Understand the source comparison
Pinealon Dosage Guide: Research Application Comparison
Standard 10-Day Cycle 1mg daily 10 days 10–14 days 10mg Subcutaneous Most common protocol in published neurological aging studies; baseline for first-time research applications Extended 20-Day Cycle 20 days 14–21 days 20mg Used in longer observational studies;
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Standard 10-Day Cycle
- 1mg daily
- 10 days
- 10–14 days
- 10mg
- Subcutaneous
- Most common protocol in published neurological aging studies; baseline for first-time research applications
- Extended 20-Day Cycle
- 20 days
- 14–21 days
- 20mg
- Used in longer observational studies; higher total peptide load per cycle without increasing per-injection dose
- High-Dose 10-Day Cycle
- 2mg daily
- Less common; explored in protocols targeting acute neuroprotection models; no published data demonstrating superiority over standard 1mg dose
- Maintenance Protocol
- 1mg every 3 days
- Continuous (30–60 days)
- Not specified
- 10mg per 30 days
- Investigated in some Russian research centers; limited peer-reviewed data; receptor desensitization risk with continuous administration